Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

November
22
2021

Treatment for Squamous Cell Carcinoma

Squamous cell carcinoma is a common form of skin cancer that develops in the squamous cells that make up the middle and outer layers of the skin. Though usually not life-threatening, this cancer can be…

November
04
2021

Sensus Healthcare Reports Third Quarter 2021 Financial Results

Achieves profitability on revenues of $5.5 million, up sharply from $1.6 million a year ago Affirms expectations for continued growth in 4Q and full-year profitability Conference call begins at 4:30 p.m. Eastern time today BOCA…

October
20
2021

Sensus Healthcare to Host Third Quarter 2021 Financial Results and Business Update Conference Call on November 4, 2021

BOCA RATON, Fla, Oct. 20, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference…

October
15
2021

Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest

Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11:00 a.m. ET BOCA RATON, Fla, Oct. 15, 2021 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy